FDA Should Seek Outside Input On Breast Implant Consent Issues - Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA should confer with the American Society of Plastic Surgeons and other appropriate professional societies regarding the types of information that should be provided to breast implant recipients regarding differences in surgical procedures and post-operative care, members of the agency's General and Plastic Surgery Devices Panel recommended March 3 in Gaithersburg, Maryland.